___
1. Finkelstein JD. Methionine metabolism in mammals. J Nutr Bioc- hem 1990;1:228-36.
2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
3. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-27.
4. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly popula- tions. J Am Med Assoc 1993;270:2693-8.
5. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-Adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharma- col Ther 1997;73:265-80.
6. Cravo ML, Gloria LM, Selhub J, et al. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vita- min B-6 status. Am J Clin Nutr 1996;63:220-4.
7. Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993;17:687-9.
8. Lambert D, Benhayoun S, Adjalla C, et al. Alcoholic cirrhosis and cobalamin metabolism. Digestion 1997;58:64-71.
9. Halsted CH, Villanueva J, Chandler CJ, et al. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocel- lular apoptosis and proliferation. Hepatology 1996;23:497-505.
10. Varela-Moreiras G, Alonso-Aperte E, Rubio M, et al. Carbon tet- rachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethi- onine treatment. Hepatology 1995;22:1310-5.
11. Lentz SR. Homocysteine and vascular dysfunction. Life Sci 1997;61:1205-15.
12. McCully KS. Homocysteine and vascular disease. Nature Med 1996;2:386-9.
13. Tyagi SC. Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. Clin Exp Hypertens 1999;21:181-98.
14. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atheroscle- rosis. Proc Natl Acad Sci USA 1994;91:6369-73.
15. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumula- tion by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81.
16. Karmin O, Lynn EG, Chung YH, et al. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Bi- ophys Acta 1998;1393:317-24.
17. Yi P, Melnyk S, Pogribna M, et al. Increase in plasma homocystei- ne associated with parallel increases in plasma S-adenosylhomocy- steine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29318-23.
18. Garcia-Tevijano ER, Berasain C, Rodríguez JA, et al. Hyperhomocy- steinemia in liver cirrhosis mechanisms and role in vascular and he- patic fibrosis. Hypertension 2001;38:1217-21.
19. Adinolfi LE, Ingrosso D, Cesaro G, et al. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibro- sis in chronic hepatitis C patients. Hepatology 2005;41:995-1003.
20. Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct 2005;23:51-4.
21. Watanabe M, Osada J, Aratani Y, et al. Mice deficient in cystathi- onine beta-synthase: animal models for mild and severe homocy- steinemia. Proc Natl Acad Sci USA 1995;92:1585-9.
22. Gülflen M, Yeflilova Z, Ba¤c› S, et al. Elevated plasma homocystei- ne concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2005;20: 1448-55.
23. Werstuck GH, Lentz SR, Dayal S, et al. Homocysteine-induced en- doplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107: 1263-73.
24. Golbahar J, Aminzadeh MA, Kassab SE, Omrani GR. Hyperhomocy- steinemia induces insulin resistance in male Sprague-Dawley rats. Diabetes Res Clin Pract 2007;76:1-5.
25. Altinova AE, Toruner F, Bukan N, et al. Decreased plasma adipo- nectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J 2007;54:221-6.
26. Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocystei- ne levels in the insulin resistance syndrome: the Framingham Offs- pring Study. Diabetes Care 2001;24:1403-10.
27. Ascencio C, Torres N, Isoard-Acosta F, et al. Soy protein affects se- rum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 2004;134:522-9.
28. Song Z, Zhou Z, Uriarte S, et al. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiolo- gical factor in alcoholic liver disease. Hepatology 2004;40:989-97.
29. Wang G, Siow YL, O K. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expressi- on in vascular smooth-muscle cells: a possible role for protein kina- se C. Biochem J 2000;352:817-26.
30. Torres L, García-Trevijano ER, Rodríguez JA, et al. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim Biophys Acta 1999;1455:12-22.
31. Duong FH, Filipowicz M, Tripodi M, et al. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004;126:263-77.
32. Kharbanda KK. Role of transmethylation reactions in alcoholic liver disease. World J Gastroenterol 2007;13:4947-54.